Central Venous Catheter Thrombosis in Cancer: A Multi-Centre Retrospective Study Investigating Risk Factors and Contemporary Trends in Management by Haggstrom, Lucy, Parmar, Gurdeep, Brungs, Daniel

Get full text

PB2077: COMPARISON OF PLASMA CELL PERCENTAGE BY BONE MARROW ASPIRATE MORPHOLOGY AND CD138-STAINED BONE MARROW BIOPSY IN SMOLDERING MYELOMA TO PREDICT TRANSFORMATION TO SYMPTOMATIC... by Cashman, Helen, Parmar, Gurdeep

Get full text

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study by Lesokhin, Alexander, LeBlanc, Richard, Dimopoulos, Meletios A., Capra, Marcelo, Carlo‐Stella, Carmelo, Karlin, Lionel, Castilloux, Jean‐Francois, Forsberg, Peter, Parmar, Gurdeep, Tosikyan, Axel, Pour, Ludek, Ribrag, Vincent, Ribolla, Rossella, Abdallah, Al‐Ola, Le Roux, Nadia, Dong, Liyan, Velde, Helgi, Mayrargue, Laurent, Lépine, Lucie, Macé, Sandrine, Moreau, Philippe

Get full text

PB2077: COMPARISON OF PLASMA CELL PERCENTAGE BY BONE MARROW ASPIRATE MORPHOLOGY AND CD138‐STAINED BONE MARROW BIOPSY IN SMOLDERING MYELOMA TO PREDICT TRANSFORMATION TO SYMPTOMATIC... by Cashman, Helen, Parmar, Gurdeep

Get full text

Differences in survival of patients with multiple myeloma in rural versus metropolitan regions: Analysis of population data of an Australian local health district by Ai, Sylvia, Thind, Amarinder, Parmar, Gurdeep

Get full text

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial by Moreau, Philippe, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Špička, Ivan, Baker, Ross, Kim, Kihyun, Martinez, Gracia, Min, Chang-Ki, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Koh, Youngil, Suzuki, Kenshi, Risse, Marie-Laure, Asset, Gaelle, Macé, Sandrine, Martin, Thomas, Moreau, Philippe, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Spicka, Ivan, Baker, Ross, Kihyun, Kim, Martinez, Gracia, Chang-Ki, Min, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Youngil, Koh, Suzuki, Kenshi, Martin, Tom, Quach, Hang, Lim, Andrew, Crowther, Helen, Sia, Hanlon, Hulin, Cyrille, Mohty, Mohamad, Mikala, Gabor, Nagy, Zsolt, Reinoso Segura, Marta, Rosinol, Laura, Yagci, Munci, Turgut, Mehmet, Garg, Mamta, Parmar, Gurdeep, Augustson, Brad, Castro, Nelson, Crusoe, Edvan, Pika, Tomas, Delimpasi, Sosana, Ishizawa, Kenichi, George, Anup, Konstantinova, Tatiana, De La Rubia, Javier, Sung-Hyun, Kim, Maiolino, Angelo, Reiman, Anthony, LeBlanc, Richard, Ito, Shigeki, Tanaka, Junji, Luchinin, Alexander, Kryuchkova, Irina, Martinez, Joaquin, Shustik, Jesse, Karlin, Lionel, Symeonidis, Anargyros, Egyed, Miklos, Petrini, Mario, Cavo, Michele, Uchiyama, Michihiro, Blacklock, Hilary, Arat, Mutlu, Griffin, James, Hunter, Hannah, Buck, Tonda, Anagnostopoulos, Achilles, Konstantopoulos, Konstantinos, Masszi, Tamas, Bringhen, Sara, Gamberi, Barbara, Kawano, Yawara, Jin Seok, Kim, Ozdogu, Hakan, Ozkalemkas, Fahir

Get full text

Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma by Quach, Hang, Parmar, Gurdeep, Mateos, Maria-Victoria, Ailawadhi, Sikander, Leleu, Xavier

Get full text

Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Combination with Daratumumab and Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma: Safety and Efficacy Results from... by Nooka, Ajay K., Cochrane, Tara, D'Souza, Anita, Matous, Jeffrey V, Voorhees, Peter M., Ramasamy, Karthik, Perrot, Aurore, Spencer, Andrew, Hulin, Cyrille, Quach, Hang, Vishwamitra, Deeksha, Nguyen, Ashley, Ghosh, Debopriya, Shearin, Elizabeth, Mason, Gary E, Renaud, Thomas, Parmar, Gurdeep

Get full text

A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma by Hang Quach, Gurdeep Parmar, Enrique M. Ocio, H. Miles Prince, Albert Oriol, Helen Crowther, Nobuhiro Tsukada, Pierre Bories, Sumit Madan, Nitya Nathwani, Kazutaka Sunami, Dorothee Semiond, Disa Yu, Paul Cordero, Sandrine Macé, Florence Suzan, Philippe Moreau

Get full text

Health-Related Quality of Life (HRQoL) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplantation and Treated with Isatuximab, Bortezomib, Lenalidomide... by Dimopoulos, Meletios, Facon, Thierry, Beksac, Meral, Pour, Ludek, Hajek, Roman, Liu, Zhuogang, Minarik, Jiri, Moreau, Philippe, Romejko-Jarosinska, Joanna, Špička, Ivan, Vorobyev, Vladimir I., Besemer, Britta, Ishida, Tadao, Janowski, Wojciech, Kalayoglu Besisik, Sevgi, Parmar, Gurdeep, Robak, Pawel, Zamagni, Elena, Goldschmidt, Hartmut, Martin, Thomas, Manier, Salomon, Mohty, Mohamad, Orlowski, Robert Z., Comerford, Erin, Tian, Claire, Msihid, Jérôme, Lin, Feng, Rhoten, Stephanie, Leleu, Xavier. P

Get full text

Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma... by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Madan, Sumit, Semiond, Dorothee, Yu, Disa, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

A multicenter, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M, Prince, H Miles, Oriol, Albert, Crowther, Helen, Tsukada, Nobuhiro, Bories, Pierre, Madan, Sumit, Nathwani, Nitya, Sunami, Kazutaka, Semiond, Dorothee, Yu, Disa, Cordero, Paul, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

A Multi-Center, Phase 1b Study to Assess the Safety, Pharmacokinetics and Efficacy of Subcutaneous Isatuximab Plus Pomalidomide and Dexamethasone, in Patients with Relapsed/Refract... by Moreau, Philippe, Parmar, Gurdeep, Prince, Miles, Ocio, Enrique, Karanes, Chatchada, Madan, Sumit, Oriol, Albert, Bories, Pierre, Delforge, Michel, Gabrail, Nashat, Semiond, Dorothee, Jia, Nan, Macé, Sandrine, Suzan, Florence, van de Velde, Helgi, Quach, Hang

Get full text

Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Itha... by Mateos, Maria-Victoria, Rodriguez Otero, Paula, Koh, Youngil, Martinez-Lopez, Joaquin, Parmar, Gurdeep, Prince, H. Miles, Quach, Hang, Ribas, Paz, Hermansen, Emil, Hungria, Vania T.M., Besisik, Sevgi Kalayoglu, Kim, Jin Seok, Leleu, Xavier, Pečeliūnas, Valdas, Schjesvold, Fredrik, Sevindik, Omur G., Lavrova, Tatiana, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Morisse, Mony, Ghobrial, Irene

Get full text

P-306 Final results of a Phase 1b study of subcutaneous isatuximab administration by an on-body delivery system (OBDS) plus pomalidomide and dexamethasone in relapsed/refractory mu... by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique, Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Madan, Sumit, Semiond, Dorothee, Yu, Disa, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

MM-071 Subcutaneous (SC) Isatuximab (Isa) Administration by an On-Body Delivery System (OBDS) in Combination With Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple My... by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

Poster: MM-071 Subcutaneous (SC) Isatuximab (Isa) Administration by an On-Body Delivery System (OBDS) in Combination With Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Mul... by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M., Prince, H. Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

P-267: Subcutaneous isatuximab administration by an on-body delivery system in combination with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: interim... by Quach, Hang, Parmar, Gurdeep, Ocio, Enrique, Prince, H Miles, Oriol, Albert, Tsukada, Nobuhiro, Sunami, Kazutaka, Bories, Pierre, Karanes, Chatchada, Madan, Sumit, Semiond, Dorothee, Inchauspe, Marlene, Macé, Sandrine, Suzan, Florence, Moreau, Philippe

Get full text

Corrigendum to P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients... by Moreau, Philippe, Parmar, Gurdeep, Prince, Miles, Ocio, Enrique, Karenes, Chatchada, Madan, Sumit, Oriol, A, Bories, Pierre, Delforge, Michel, Galbrail, Nashat, Semiond, Dorothee, Jia, Nan, Macé, Sandrine, Suzan, Florence, de Velde, Helgivan

Get full text

P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/... by Moreau, Philippe, Parmar, Gurdeep, Prince, Miles, Ocio, Enrique, Karenes, Chatchada, Madan, Sumit, Oriol, A, Bories, Pierre, Delforge, Michel, Galbrail, Nashat, Semiond, Dorothee, Jia, Nan, Macé, Sandrine, Suzan, Florence, van de Velde, Helgi

Get full text